MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment

被引：0
作者：
Vincenzo Calvanese
Andrew T. Nguyen
Timothy J. Bolan
Anastasia Vavilina
Trent Su
Lydia K. Lee
Yanling Wang
Fides D. Lay
Mattias Magnusson
Gay M. Crooks
Siavash K. Kurdistani
Hanna K. A. Mikkola
机构：
[1] University of California Los Angeles,Department of Molecular, Cell and Developmental Biology
[2] University of California Los Angeles,Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research
[3] University of California Los Angeles,Department of Biological Chemistry
[4] University of California Los Angeles,Department of Obstetrics and Gynecology
[5] University of California Los Angeles,Department of Pathology and Laboratory Medicine, David Geffen School of Medicine
[6] University of California Los Angeles,Jonsson Comprehensive Cancer Center
[7] University of California Los Angeles,Molecular Biology Institute
来源：
Nature | 2019年 / 576卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Limited knowledge of the mechanisms that govern the self-renewal of human haematopoietic stem cells (HSCs), and why this fails in culture, have impeded the expansion of HSCs for transplantation1. Here we identify MLLT3 (also known as AF9) as a crucial regulator of HSCs that is highly enriched in human fetal, neonatal and adult HSCs, but downregulated in culture. Depletion of MLLT3 prevented the maintenance of transplantable human haematopoietic stem or progenitor cells (HSPCs) in culture, whereas stabilizing MLLT3 expression in culture enabled more than 12-fold expansion of transplantable HSCs that provided balanced multilineage reconstitution in primary and secondary mouse recipients. Similar to endogenous MLLT3, overexpressed MLLT3 localized to active promoters in HSPCs, sustained levels of H3K79me2 and protected the HSC transcriptional program in culture. MLLT3 thus acts as HSC maintenance factor that links histone reader and modifying activities to modulate HSC gene expression, and may provide a promising approach to expand HSCs for transplantation.
引用
收藏
页码：281 / 286
页数：5
相关论文
共 62 条
[21]  
Armstrong SA(2013)Potent inhibition of DOT1L as treatment of MLL-fusion leukemia Leukemia 27 2064-2073
[22]  
Pina C(2016)MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny Leukemia 30 144-155
[23]  
May G(2016)Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model Cell Stem Cell 18 156-164
[24]  
Soneji S(2018)Phase I/II trial of stemregenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft Mol. Ther. Methods Clin. Dev. 10 117-121
[25]  
Hong D(2019)UM171 Enhances Lentiviral Gene Transfer And Recovery Of Primitive Human Hematopoietic Cells Nature 571 2403-2416
[26]  
Enver T(2011)Long-term J. Exp. Med. 208 508-511
[27]  
McKinney-Freeman S(2016) haematopoietic-stem-cell expansion allows nonconditioned transplantation Nature 532 3514-3523
[28]  
Ng ES(2017)Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity Cell Reports 21 70-78
[29]  
Boitano AE(2009)Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells J. Immunol. Methods 347 759-777
[30]  
Fares I(2015)Hepatic leukemia factor maintains quiescence of hematopoietic stem cells and protects the stem cell pool during regeneration EMBO J. 34 576-589
1234567